New Two-Pronged attack on Tough-to-Treat blood cancer
NCT ID NCT05090566
Summary
This study is testing a new drug called elranatamab in combination with other cancer therapies for people with multiple myeloma that has come back or stopped responding to several prior treatments. The main goals are to find the safest and most effective dose and to see if these drug combinations can help control the cancer. It is for patients who have already tried at least three other treatment lines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2, Canada
-
Banner Gateway Medical Center
Gilbert, Arizona, 85234, United States
-
Banner Gateway Medical Pavilion
Gilbert, Arizona, 85234, United States
-
Banner Health d.b.a. Banner MD Anderson Cancer Center
Phoenix, Arizona, 85012, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Beverly Hills Cancer Center
Beverly Hills, California, 90211, United States
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD
Los Angeles, California, 90048, United States
-
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI)
Los Angeles, California, 90048, United States
-
Cedars-Sinai Tarzana
Tarzana, California, 91356, United States
-
Clinical Research Advisors
Encino, California, 91316, United States
-
Clinical Research Advisors
Los Angeles, California, 90020, United States
-
Clinical Research Advisors
Los Angeles, California, 90048, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida, 33146, United States
-
Sylvester Comprehensive Cancer Center- Deerfield Beach
Deerfield Beach, Florida, 33442, United States
-
The Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility)
Baltimore, Maryland, 21231, United States
-
UHealth Tower
Miami, Florida, 33136, United States
-
University of Miami
Coral Gables, Florida, 33146, United States
Conditions
Explore the condition pages connected to this study.